Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
Identifieur interne : 004699 ( PubMed/Curation ); précédent : 004698; suivant : 004700Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
Auteurs : K. Ikeda [Japon] ; M. Kinoshita ; K. Aoki ; A. TomatsuriSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Carbidopa (administration & dosage), Combined Modality Therapy, Drug Therapy, Combination, Female, Humans, Hydrocephalus (etiology), Hydrocephalus (therapy), Levodopa (administration & dosage), Neurologic Examination (drug effects), Osteitis Deformans (complications), Osteitis Deformans (therapy), Parkinson Disease, Secondary (etiology), Parkinson Disease, Secondary (therapy), Ventriculoperitoneal Shunt.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Levodopa.
- complications : Osteitis Deformans.
- drug effects : Neurologic Examination.
- etiology : Hydrocephalus, Parkinson Disease, Secondary.
- therapy : Hydrocephalus, Osteitis Deformans, Parkinson Disease, Secondary.
- Aged, Combined Modality Therapy, Drug Therapy, Combination, Female, Humans, Ventriculoperitoneal Shunt.
DOI: 10.1002/mds.870120217
PubMed: 9087985
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004699
Links to Exploration step
pubmed:9087985Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.</title><author><name sortKey="Ikeda, K" sort="Ikeda, K" uniqKey="Ikeda K" first="K" last="Ikeda">K. Ikeda</name><affiliation wicri:level="1"><nlm:affiliation>Fourth Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Fourth Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Kinoshita, M" sort="Kinoshita, M" uniqKey="Kinoshita M" first="M" last="Kinoshita">M. Kinoshita</name></author><author><name sortKey="Aoki, K" sort="Aoki, K" uniqKey="Aoki K" first="K" last="Aoki">K. Aoki</name></author><author><name sortKey="Tomatsuri, A" sort="Tomatsuri, A" uniqKey="Tomatsuri A" first="A" last="Tomatsuri">A. Tomatsuri</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1997">1997</date><idno type="RBID">pubmed:9087985</idno><idno type="pmid">9087985</idno><idno type="doi">10.1002/mds.870120217</idno><idno type="wicri:Area/PubMed/Corpus">004699</idno><idno type="wicri:Area/PubMed/Curation">004699</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.</title><author><name sortKey="Ikeda, K" sort="Ikeda, K" uniqKey="Ikeda K" first="K" last="Ikeda">K. Ikeda</name><affiliation wicri:level="1"><nlm:affiliation>Fourth Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Fourth Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo</wicri:regionArea></affiliation></author><author><name sortKey="Kinoshita, M" sort="Kinoshita, M" uniqKey="Kinoshita M" first="M" last="Kinoshita">M. Kinoshita</name></author><author><name sortKey="Aoki, K" sort="Aoki, K" uniqKey="Aoki K" first="K" last="Aoki">K. Aoki</name></author><author><name sortKey="Tomatsuri, A" sort="Tomatsuri, A" uniqKey="Tomatsuri A" first="A" last="Tomatsuri">A. Tomatsuri</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="1997" type="published">1997</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (administration & dosage)</term><term>Carbidopa (administration & dosage)</term><term>Combined Modality Therapy</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Hydrocephalus (etiology)</term><term>Hydrocephalus (therapy)</term><term>Levodopa (administration & dosage)</term><term>Neurologic Examination (drug effects)</term><term>Osteitis Deformans (complications)</term><term>Osteitis Deformans (therapy)</term><term>Parkinson Disease, Secondary (etiology)</term><term>Parkinson Disease, Secondary (therapy)</term><term>Ventriculoperitoneal Shunt</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Carbidopa</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Osteitis Deformans</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hydrocephalus</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hydrocephalus</term><term>Osteitis Deformans</term><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Combined Modality Therapy</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Ventriculoperitoneal Shunt</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9087985</PMID><DateCreated><Year>1997</Year><Month>07</Month><Day>17</Day></DateCreated><DateCompleted><Year>1997</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>1997</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.</ArticleTitle><Pagination><MedlinePgn>241-2</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Fourth Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tomatsuri</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical><Chemical><RegistryNumber>MNX7R8C5VO</RegistryNumber><NameOfSubstance UI="D002230">Carbidopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002230">Carbidopa</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003131">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006849">Hydrocephalus</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010001">Osteitis Deformans</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010302">Parkinson Disease, Secondary</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D017287">Ventriculoperitoneal Shunt</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9087985</ArticleId><ArticleId IdType="doi">10.1002/mds.870120217</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004699 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004699 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:9087985
|texte= Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:9087985" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |